Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Beck

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
Medecine Sciences : M/S|January 7, 2020
[A word from the coordinators]André Pèlegrin, Alain Beck, Hervé Watier
Medecine Sciences : M/S|January 7, 2020
[Antibody-drug conjugates in oncology. New strategies in development]Alain Beck, Charles Dumontet, Nicolas Joubert
Mabs|June 22, 2011
World Antibody Drug Conjugate Summit Europe: February 21-23, 2011; Frankfurt, GermanyAlain Beck, Peter Senter, Ravi Chari
The Analyst|May 10, 2016
Rapid and improved characterization of therapeutic antibodies and antibody related products using IdeS digestion and subunit analysisJonathan Sjögren, Fredrik Olsson, Alain Beck
Mabs|June 6, 2023
Effects of the COVID-19 pandemic: new approaches for accelerated delivery of gene to first-in-human CMC data for recombinant proteinsHervé Broly, Jonathan Souquet, Alain Beck
Expert Opinion on Drug Discovery|July 25, 2012
GlycoFi's technology to control the glycosylation of recombinant therapeutic proteinsAlain Beck, Olivier Cochet, Thierry Wurch
Journal of Pharmaceutical and Biomedical Analysis|April 19, 2015
Characterization of cation exchanger stationary phases applied for the separations of therapeutic monoclonal antibodiesSzabolcs Fekete, Alain Beck, Davy Guillarme
Medecine Sciences : M/S|January 7, 2020
[Antibody-drug conjugates in oncology. Recent success of an ancient concept]Alain Beck, Charles Dumontet, Nicolas Joubert
Mabs|August 7, 2012
2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USAMitchell Ho, Ivor Royston, Alain Beck
Medecine Sciences : M/S|December 29, 2009
[Monoclonal antibodies for treating infectious diseases]Christine Klinguer-Hamour, Véronique Caussanel, Alain Beck
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
Medecine Sciences : M/S|January 7, 2020
[A word from the coordinators]André Pèlegrin, Alain Beck, Hervé Watier
Medecine Sciences : M/S|January 7, 2020
[Antibody-drug conjugates in oncology. New strategies in development]Alain Beck, Charles Dumontet, Nicolas Joubert
Mabs|June 22, 2011
World Antibody Drug Conjugate Summit Europe: February 21-23, 2011; Frankfurt, GermanyAlain Beck, Peter Senter, Ravi Chari
The Analyst|May 10, 2016
Rapid and improved characterization of therapeutic antibodies and antibody related products using IdeS digestion and subunit analysisJonathan Sjögren, Fredrik Olsson, Alain Beck
Mabs|June 6, 2023
Effects of the COVID-19 pandemic: new approaches for accelerated delivery of gene to first-in-human CMC data for recombinant proteinsHervé Broly, Jonathan Souquet, Alain Beck
Expert Opinion on Drug Discovery|July 25, 2012
GlycoFi's technology to control the glycosylation of recombinant therapeutic proteinsAlain Beck, Olivier Cochet, Thierry Wurch
Journal of Pharmaceutical and Biomedical Analysis|April 19, 2015
Characterization of cation exchanger stationary phases applied for the separations of therapeutic monoclonal antibodiesSzabolcs Fekete, Alain Beck, Davy Guillarme
Medecine Sciences : M/S|January 7, 2020
[Antibody-drug conjugates in oncology. Recent success of an ancient concept]Alain Beck, Charles Dumontet, Nicolas Joubert
Mabs|August 7, 2012
2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USAMitchell Ho, Ivor Royston, Alain Beck
Medecine Sciences : M/S|December 29, 2009
[Monoclonal antibodies for treating infectious diseases]Christine Klinguer-Hamour, Véronique Caussanel, Alain Beck
Pageof 19